WallStreetZenWallStreetZen

NASDAQ: AEZS
Aeterna Zentaris Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AEZS past revenue growth

How has AEZS's revenue growth performed historically?
Company
22.35%
Industry
69.78%
Market
14.1%
AEZS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AEZS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AEZS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AEZS earnings and revenue history

Current Revenue
$6.3M
Current Earnings
-$24.3M
Current Profit Margin
-389.4%

AEZS Return on Equity

Current Company
-57%
Current Industry
-18%
Current Market
30.8%
AEZS's Return on Equity (-57%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AEZS announces earnings.

AEZS Return on Assets

Current Company
-39.6%
Current Industry
0.9%
AEZS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AEZS Return on Capital Employed

Current Company
-54.28%
Current Industry
14.1%
AEZS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AEZS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AEZS$6.25M-$24.20M-$24.34M-24.40%N/A
EVLO$0.00-$99.17M-$110.01MN/AN/A
APRE$0.00-$109.69M-$109.11MN/AN/A
ACGN$0.00-$29.87M-$23.36M-100.00%N/A
IBIO$61.00k-$73.71M-$76.03M-34.34%N/A
View Top Biotech Stocks

AEZS earnings dates

Next earnings date
Aug 1, 2023

Aeterna Zentaris Earnings & Revenue FAQ

What were AEZS's earnings last quarter?

On Invalid Date, Aeterna Zentaris (NASDAQ: AEZS) reported Q1 2023 earnings per share (EPS) of -$0.88, up 62.96% year over year. Total Aeterna Zentaris earnings for the quarter were -$4.26 million. In the same quarter last year, Aeterna Zentaris's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Aeterna Zentaris stock.

What was AEZS's earnings growth in the past year?

As of Q2 2023, Aeterna Zentaris's earnings has grown year over year. Aeterna Zentaris's earnings in the past year totalled -$24.34 million.

What is AEZS's earnings date?

Aeterna Zentaris's earnings date is Invalid Date. Add AEZS to your watchlist to be reminded of AEZS's next earnings announcement.

What was AEZS's revenue last quarter?

On Invalid Date, Aeterna Zentaris (NASDAQ: AEZS) reported Q1 2023 revenue of $2.13 million up 40.28% year over year. In the same quarter last year, Aeterna Zentaris's revenue was $1.52 million.

What was AEZS's revenue growth in the past year?

As of Q2 2023, Aeterna Zentaris's revenue has grown 22.35% year over year. This is 47.42 percentage points lower than the US Biotechnology industry revenue growth rate of 69.78%. Aeterna Zentaris's revenue in the past year totalled $6.25 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.